Preliminary Q2 2026 Rxsight Inc Earnings Call Transcript
Hello, and thank you for standing by. My name is John, and I will be your conference operator today. At this time, I would like to welcome everyone to the RxSight preliminary second-quarter financial results and product pipeline updates following Collaboration Agreement. (Operator Instructions)
I would now like to turn the conference over to Oliver Moravcevic, VP of Investor Relations. Please go ahead.
Thank you, operator. With me on the call this morning is RxSight President and Chief Executive Officer, Dr. Ron Kurtz; and Chief Financial Officer, Mark Wilterding. Yesterday, RxSight released a pair of press releases, one reporting a new Collaboration Agreement with Alcon and the second reporting preliminary revenue results for the three months ending June 30, 2026, updated product pipeline and revised full-year guidance. Copies of both press releases and corresponding 8-Ks are available on the company's website.
Before we begin, I would like to inform you that comments and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

